These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 27956539)

  • 1. Delivery of Adjuvant Oxaliplatin for Colon Cancer: Insights From Routine Clinical Practice.
    Satkunam N; Wei X; Biagi JJ; Nanji S; Booth CM
    J Natl Compr Canc Netw; 2016 Dec; 14(12):1548-1554. PubMed ID: 27956539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.
    Sanoff HK; Carpenter WR; Stürmer T; Goldberg RM; Martin CF; Fine JP; McCleary NJ; Meyerhardt JA; Niland J; Kahn KL; Schymura MJ; Schrag D
    J Clin Oncol; 2012 Jul; 30(21):2624-34. PubMed ID: 22665536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults.
    Mack CD; Carpenter W; Meyer AM; Sanoff H; Stürmer T
    Cancer; 2012 Jun; 118(11):2925-34. PubMed ID: 22072441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy.
    Mack CD; Glynn RJ; Brookhart MA; Carpenter WR; Meyer AM; Sandler RS; Stürmer T
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):810-8. PubMed ID: 23296544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Prognosis and Tumor Laterality in Early-Stage Colon Cancer.
    Karim S; Brennan K; Nanji S; Berry SR; Booth CM
    JAMA Oncol; 2017 Oct; 3(10):1386-1392. PubMed ID: 28594974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study.
    Ortiz-Ortiz KJ; Tortolero-Luna G; Ríos-Motta R; Veintidós-Feliú A; Hunter-Mellado R; Torres-Cintrón CR; Suárez-Ramos T; Magno P
    PLoS One; 2018; 13(3):e0194415. PubMed ID: 29584752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis.
    Mack CD; Brookhart MA; Glynn RJ; Meyer AM; Carpenter WR; Sandler RS; Stürmer T
    Epidemiology; 2015 Sep; 26(5):690-9. PubMed ID: 26196683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Adjuvant Chemotherapy on Early-onset Stage II Colon Cancer at Different Tumor Sites.
    Tan C; Wang Q; Yao S
    Am J Clin Oncol; 2024 Jun; 47(6):253-258. PubMed ID: 38251762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations regarding an updated meta-analysis of the optimal duration of oxaliplatin-based adjuvant chemotherapy in patients with different risk factors for stage II-III colon cancer.
    Pang H; Yan M; Chen L; Zhao Z; Li W; Zhang S; Sun H
    Int J Surg; 2024 Jul; 110(7):4431-4432. PubMed ID: 39042074
    [No Abstract]   [Full Text] [Related]  

  • 10. Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.
    Penn DC; Chang Y; Meyer AM; DeFilippo Mack C; Sanoff HK; Stitzenberg KB; Carpenter WR
    Cancer; 2015 Jan; 121(1):93-101. PubMed ID: 25209056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What We Know About Stage II and III Colon Cancer: It's Still Not Enough.
    Puccini A; Berger MD; Zhang W; Lenz HJ
    Target Oncol; 2017 Jun; 12(3):265-275. PubMed ID: 28504299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating research into practice: the role of provider-based research networks in the diffusion of an evidence-based colon cancer treatment innovation.
    Carpenter WR; Meyer AM; Wu Y; Qaqish B; Sanoff HK; Goldberg RM; Weiner BJ
    Med Care; 2012 Aug; 50(8):737-48. PubMed ID: 22437624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism.
    Lopes-Ramos CM; Kuijjer ML; Ogino S; Fuchs CS; DeMeo DL; Glass K; Quackenbush J
    Cancer Res; 2018 Oct; 78(19):5538-5547. PubMed ID: 30275053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the IDEA Collaboration Study on Real-World Practice Patterns of Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Population-Based Study.
    Samnani S; Ding PQ; Lee-Ying R; Cheung WY; Karim S
    JCO Oncol Pract; 2024 Jun; ():OP2400060. PubMed ID: 38913969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.
    Sinicrope FA; Shi Q; Allegra CJ; Smyrk TC; Thibodeau SN; Goldberg RM; Meyers JP; Pogue-Geile KL; Yothers G; Sargent DJ; Alberts SR
    JAMA Oncol; 2017 Apr; 3(4):472-480. PubMed ID: 28006055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Findings from the Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group: the power of pooled individual patient data from multiple clinical trials.
    Renfro LA; Sargent DJ
    Chin Clin Oncol; 2016 Dec; 5(6):80. PubMed ID: 28061544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant systemic chemotherapy for stages II and III colon cancer after complete resection: a clinical practice guideline.
    Meyers BM; Cosby R; Quereshy F; Jonker D
    Curr Oncol; 2016 Dec; 23(6):418-424. PubMed ID: 28050138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment delays during FOLFOX chemotherapy in patients with colorectal cancer: a multicenter retrospective analysis.
    Kogan LG; Davis SL; Brooks GA
    J Gastrointest Oncol; 2019 Oct; 10(5):841-846. PubMed ID: 31602321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Adjuvant Chemotherapy Duration and Survival Among Patients With Stage II and III Colon Cancer: A Systematic Review and Meta-analysis.
    Boyne DJ; Cuthbert CA; O'Sullivan DE; Sajobi TT; Hilsden RJ; Friedenreich CM; Cheung WY; Brenner DR
    JAMA Netw Open; 2019 May; 2(5):e194154. PubMed ID: 31099875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Japanese multicenter phase II study of adjuvant chemotherapy with mFOLFOX6/CAPOX for stage III colon cancer treatment after D2/D3 lymphadenectomy.
    Yoshimatsu K; Ishibashi K; Koda K; Yokomizo H; Oda N; Oshiro M; Kato H; Oya M; Nakajima H; Ooki S; Maekawa H; Matsunami T; Tsubaki M; Yamada T; Kobayashi M; Tanakaya K; Yokoyama M; Ishida H
    Surg Today; 2019 Jun; 49(6):498-506. PubMed ID: 30953164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.